Total Payments
$2,652
2024 Payments
$280.38
Companies
24
Transactions
97
Medicare Patients
13,067
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$2,295 (86.6%)
Travel$350.00 (13.2%)
Education$6.49 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,295 | 95 | 86.6% |
| Travel and Lodging | $350.00 | 1 | 13.2% |
| Education | $6.49 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $742.17 | 36 | $0 (2024) |
| Biogen, Inc. | $539.61 | 6 | $0 (2022) |
| Zimmer Biomet Holdings, Inc. | $350.00 | 1 | $0 (2019) |
| Allergan, Inc. | $247.22 | 13 | $0 (2022) |
| PFIZER INC. | $132.08 | 6 | $0 (2017) |
| ABBVIE INC. | $123.36 | 8 | $0 (2024) |
| LEO Pharma Inc. | $75.74 | 3 | $0 (2022) |
| Janssen Biotech, Inc. | $67.76 | 4 | $0 (2018) |
| Amgen Inc. | $48.93 | 2 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $44.02 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $280.38 | 15 | Novartis Pharmaceuticals Corporation ($261.66) |
| 2023 | $177.50 | 8 | AbbVie Inc. ($57.41) |
| 2022 | $282.98 | 8 | Biogen, Inc. ($155.36) |
| 2021 | $440.94 | 8 | Biogen, Inc. ($384.25) |
| 2020 | $64.85 | 3 | Novartis Pharmaceuticals Corporation ($47.25) |
| 2019 | $767.38 | 20 | Zimmer Biomet Holdings, Inc. ($350.00) |
| 2018 | $123.23 | 8 | Janssen Biotech, Inc. ($37.80) |
| 2017 | $514.27 | 27 | Allergan Inc. ($166.49) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Dermatology | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: Dermatology | ||||||
| 10/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Dermatology | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $2.39 | General |
| Category: Dermatology | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Dermatology | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: Dermatology | ||||||
| 06/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Dermatology | ||||||
| 05/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Dermatology | ||||||
| 04/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Dermatology | ||||||
| 04/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.41 | General |
| Category: Dermatology | ||||||
| 02/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: Dermatology | ||||||
| 02/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: Dermatology | ||||||
| 10/16/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Inflammation | ||||||
| 03/10/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $24.25 | General |
| 03/07/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Inflammation | ||||||
| 01/20/2023 | AstraZeneca Pharmaceuticals LP | EVUSHELD (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Vaccines & Immune Therapies | ||||||
| 01/11/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Dermatology | ||||||
| 01/11/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/12/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: FACIAL AESTHETICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,338 | 6,994 | $517,206 | $349,678 |
| 2022 | 19 | 3,155 | 6,507 | $519,745 | $342,112 |
| 2021 | 21 | 3,364 | 6,442 | $528,118 | $362,157 |
| 2020 | 18 | 3,210 | 6,158 | $461,598 | $285,732 |
Total Patients
13,067
Total Services
26,101
Medicare Billing
$1.3M
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,041 | 1,544 | $166,333 | $117,408 | 70.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 540 | 652 | $82,349 | $56,148 | 68.2% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 174 | 307 | $52,233 | $29,965 | 57.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 281 | 580 | $36,045 | $27,915 | 77.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 343 | 464 | $38,527 | $19,591 | 50.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 195 | 195 | $26,478 | $17,671 | 66.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 291 | 2,700 | $21,586 | $16,310 | 75.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 83 | 105 | $22,940 | $15,272 | 66.6% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 52 | 55 | $14,064 | $10,471 | 74.5% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 38 | 44 | $10,358 | $7,016 | 67.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 66 | 74 | $10,310 | $6,797 | 65.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 54 | $8,143 | $6,223 | 76.4% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 28 | 34 | $6,576 | $4,465 | 67.9% |
| 11307 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 29 | 39 | $6,675 | $4,078 | 61.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 17 | 20 | $4,150 | $3,250 | 78.3% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 18 | 20 | $3,245 | $2,287 | 70.5% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 20 | 20 | $3,053 | $2,182 | 71.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 38 | $2,574 | $1,649 | 64.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 19 | 22 | $1,534 | $956.42 | 62.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 27 | $32.40 | $23.35 | 72.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 939 | 1,252 | $138,132 | $98,701 | 71.5% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 295 | 538 | $94,340 | $53,174 | 56.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 358 | 412 | $53,209 | $35,160 | 66.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 223 | 223 | $31,090 | $22,040 | 70.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 340 | 464 | $39,585 | $19,653 | 49.6% |
About Dr. Mark Silverman, M.D
Dr. Mark Silverman, M.D is a Specialist healthcare provider based in Oceanside, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780674184.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Silverman, M.D has received a total of $2,652 in payments from pharmaceutical and medical device companies, with $280.38 received in 2024. These payments were reported across 97 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,295).
As a Medicare-enrolled provider, Silverman has provided services to 13,067 Medicare beneficiaries, totaling 26,101 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Oceanside, NY
- Active Since 10/26/2005
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1780674184
Products in Payments
- COSENTYX (Biological) $455.05
- Diem2 (Device) $350.00
- TYSABRI (Biological) $322.39
- COSENTYX (Drug) $287.12
- VIBERZI (Drug) $148.31
- EUCRISA (Drug) $132.08
- ADUHELM (Biological) $77.60
- BOTOX (Biological) $72.81
- Tremfya (Drug) $67.76
- Otezla (Drug) $48.93
- Humira (Biological) $47.23
- DISEASE STATE (Drug) $44.02
- SKYRIZI (Biological) $43.33
- ADBRY (Biological) $29.16
- VUMERITY (Drug) $26.66
- VALCHLOR (Drug) $24.97
- PICATO (Drug) $24.96
- ACZONE (Drug) $23.28
- FINACEA (Drug) $21.62
- EVUSHELD (Drug) $21.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Oceanside
Michael Guerena, Md, MD
Specialist — Payments: $14,702
Specialist $14,702
Dr. Bradley Frasier, Md, MD
Specialist — Payments: $14,314
Specialist $14,314
Dr. Tannaz Ebrahimi Adib, M.d, M.D
Specialist — Payments: $13,060
Specialist $13,060
Dr. Margot Aiken, Md, MD
Specialist — Payments: $11,376
Specialist $11,376
Katayoun Toosie, M.d, M.D
Specialist — Payments: $10,294
Specialist $10,294
Dr. Julie Aspiras, M.d, M.D
Specialist — Payments: $8,403
Specialist $8,403